EMEA-001214-PIP01-11-M08

Key facts

Invented name
Fasenra
Active substance
benralizumab
Therapeutic area
Pneumology-allergology
Decision number
P/0244/2018
PIP number
EMEA-001214-PIP01-11-M08
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of asthma
Route(s) of administration
Subcutaneous use
Contact for public enquiries
AstraZeneca AB (UK)

E-mail: paediatrics@medimmune.com
Tel. +44 1223471471

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating